Nanoviricides Inc
(NNVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,912 | -4,802 | -2,006 | -10,305 | -7,747 |
| Depreciation Amortization | 867 | 696 | 408 | 2,011 | 1,620 |
| Accounts payable and accrued liabilities | 1,408 | 1,074 | 433 | -388 | -751 |
| Other Working Capital | 1,638 | 975 | 403 | -486 | -1,190 |
| Other Operating Activity | -1,257 | -904 | -795 | 1,270 | 1,179 |
| Operating Cash Flow | $-4,256 | $-2,961 | $-1,557 | $-7,898 | $-6,889 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -225 | -93 | -30 | -165 | -119 |
| Investing Cash Flow | $-225 | $-93 | $-30 | $-165 | $-119 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -1,000 | -1,000 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $-1,000 | $-1,000 |
| Beginning Cash Position | 15,100 | 15,100 | 15,100 | 24,162 | 24,162 |
| End Cash Position | 10,618 | 12,046 | 13,512 | 15,100 | 16,155 |
| Net Cash Flow | $-4,482 | $-3,053 | $-1,587 | $-9,063 | $-8,007 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,256 | -2,961 | -1,557 | -7,898 | -6,889 |
| Capital Expenditure | -225 | -93 | -30 | -165 | -119 |
| Free Cash Flow | -4,482 | -3,053 | -1,587 | -8,063 | -7,007 |